Neuroendocrine Neoplasia and Endocrine Tumors: Pathogenic Features, Prognostic Markers and New Therapeutic Approaches
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 76
Special Issue Editor
2. Department of Endocrinology, C.I. Parhon National Institute of Endocrinology, 011863 Bucharest, Romania
Interests: thyroid; adrenal; pituitary; osteoporosis; neuroendocrine tumors; bone; fracture; gynecological endocrinology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The complex domain of neuroendocrine neoplasia, including endocrine tumors with neuroendocrine components, represents one of the most dynamic multidisciplinary topics that are studied today. Great progress has recently been made with new prognostic markers and therapies that are proving their utility in different applications, from clinical presentation to personalized therapeutic approaches. A stratified perspective includes a large panel of conditions underlying neuroendocrine traits that vary from very rare entities to more frequent pathologies, such as gastro-pancreatic-intestinal neuroendocrine neoplasms, depending on the tumors’ sites and profiles in both pediatric and adult populations. In addition, early prognostic markers might be useful for prompt diagnoses in subjects with hereditary conditions or patients harboring pathogenic variants of different genes.
Dr. Mara Carsote
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroendocrine tumors
- endocrine tumors
- somatostatin analogues
- carcinoid syndrome
- PRRT
- mTOR inhibitor
- lymph node
- neuroendocrine marker
- hormone
- ki67
